SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-014026
Filing Date
2024-02-12
Accepted
2024-02-12 12:39:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm245912d1_defa14a.htm DEFA14A 81296
2 GRAPHIC tm245912d1_img001.jpg GRAPHIC 10158
  Complete submission text file 0001104659-24-014026.txt   96571
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 24618615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)